Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
With
Perseid Therapeutics LLC
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject has rheumatoid arthritis (RA), is both abatacept- and belatacept-naïve, and is an eligible candidate to start a course of treatment with abatacept in accordance with the product label
Subject is willing and able to comply with study visits and procedures
Clareo Health | A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept
